New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists
Neuropsychiatric Disease and Treatment · 2024-03 · Volume 20 · 607-620
DOI: 10.2147/ndt.s455279 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2024-03. Verfasst von Aineng Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China.
- Heilongjiang Mental Hospital, Harbin, 150036, People's Republic of China.
- Tongde Hospital of Zhejiang Province, Hangzhou, 311100, People's Republic of China.
Zitieren
APA
Peng, A., Chai, J., Wu, H., Bai, B., Yang, H., He, W., & Zhao, Y. (2024). New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists. Neuropsychiatric Disease and Treatment, Volume 20, 607-620. https://doi.org/10.2147/ndt.s455279
Vancouver
Peng A, Chai J, Wu H, Bai B, Yang H, He W, et al. New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists. Neuropsychiatric Disease and Treatment. 2024;Volume 20:607-620. doi:10.2147/ndt.s455279
BibTeX
@article{Peng2024,
author = {Peng, Aineng and Chai, Jianbo and Wu, Haiyuan and Bai, Bing and Yang, Huihui and He, Weizhi and Zhao, Yonghou},
title = {New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists},
journal = {Neuropsychiatric Disease and Treatment},
year = {2024},
volume = {Volume 20},
pages = {607--620},
doi = {10.2147/ndt.s455279}
}
EUVIMED